Hyliion Holdings Corp (HYLN) is the target of a securities lawsuit alleging it failed to assess whether a counterparty with only four staff members could deliver on a $133 million KARNO project. The case was filed by Levi & Korsinsky in September 2026.
The law firm Levi & Korsinsky has brought a securities class action against Hyliion Holdings, accusing the company of signing off on a $133 million KARNO deployment without verifying that its counterparty — a firm with just four employees — had the means to deliver.
The lawsuit, announced Sept. 9 in New York, alleges Hyliion did not evaluate or disclose whether the counterparty had the financial resources and development capability to execute the proposed deployment, according to the law firm's shareholder alert.
The allegations raise questions about the diligence process behind the $133 million KARNO deployment and whether material risks tied to the counterparty's viability were properly disclosed to shareholders.
The class action creates legal and regulatory exposure for Hyliion, whose shares trade on the NYSE under the ticker HYLN. Investors who purchased Hyliion securities during the relevant period may be eligible to seek recovery, and the outcome could affect confidence in the company's contract pipeline and revenue outlook.
Levi & Korsinsky is urging investors with losses to contact the firm to discuss their legal rights and potential lead plaintiff status. Under the Private Securities Litigation Reform Act of 1995, the court will appoint a lead plaintiff to represent the class, with the deadline for applications to be set by the court.
The lawsuit strikes at the credibility of Hyliion's KARNO deployment pipeline. A finding against Hyliion could result in financial penalties and reputational damage, while the pendency of the litigation may weigh on the stock as investors price in legal uncertainty. Investors should watch for the court's scheduling order and any subsequent disclosures from Hyliion regarding the KARNO counterparty.
This article is for informational purposes only and does not constitute investment advice.
